Clinical Trial Update: Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating yttrium-90 radioembolization before surgical resection or radiofrequency ablation for hepatocellular carcinoma in cirrhotic livers was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Hepatocellular Carcinoma, Liver Cirrhosis | Phase 2 | Status: TERMINATED